Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred R Hirsch

Showing results (41-50 of 405) with videos related to

Pageof 41
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2005
Systemic therapy of advanced bronchioloalveolar cell carcinoma: challenges and opportunitiesVincent A Miller, Fred R Hirsch, David H Johnson
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 25, 2016
Correction: "From Mice to Men and Back: An Assessment of Preclinical Model Systems for the Study of Lung Cancers"Adi F Gazdar, Fred R Hirsch, John D Minna
Lung Cancer (Amsterdam, Netherlands)|May 16, 2002
What is the role of HER-2/neu and trastuzumab (Herceptin) in lung cancer?Fred R Hirsch, Wilbur A Franklin, Paul A Bunn
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 3, 2016
From Mice to Men and Back: An Assessment of Preclinical Model Systems for the Study of Lung CancersAdi F Gazdar, Fred R Hirsch, John D Minna
The Lancet. Oncology|July 10, 2015
EGFR tyrosine kinase inhibitors in squamous cell lung cancerFred R Hirsch, Roy S Herbst, David R Gandara
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2014
"Companion diagnostics": has their time come and gone?Fred R Hirsch, Paul A Bunn, Roy S Herbst
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2014
Is there clinical value to prognostic signatures in early-stage NSCLC?Paul A Bunn, Fred R Hirsch, Dara L Aisner
Translational Lung Cancer Research|December 9, 2017
Potential future consideration for imaging and blood-based biomarkers for precision medicine in lung cancerFeng-Ming Spring Kong, Fred R Hirsch, Mitchell Machtay
Seminars in Oncology|July 3, 2002
Expression of target molecules in lung cancer: challenge for a new treatment paradigmFred R Hirsch, Wilbur A Franklin, Paul A Bunn
Small (Weinheim an Der Bergstrasse, Germany)|August 26, 2009
Sniffing the unique "odor print" of non-small-cell lung cancer with gold nanoparticlesOrna Barash, Nir Peled, Fred R Hirsch, et al.
Pageof 41

Showing results (41-50 of 405) with videos related to

Sort By:
Pageof 41
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2005
Systemic therapy of advanced bronchioloalveolar cell carcinoma: challenges and opportunitiesVincent A Miller, Fred R Hirsch, David H Johnson
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 25, 2016
Correction: "From Mice to Men and Back: An Assessment of Preclinical Model Systems for the Study of Lung Cancers"Adi F Gazdar, Fred R Hirsch, John D Minna
Lung Cancer (Amsterdam, Netherlands)|May 16, 2002
What is the role of HER-2/neu and trastuzumab (Herceptin) in lung cancer?Fred R Hirsch, Wilbur A Franklin, Paul A Bunn
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 3, 2016
From Mice to Men and Back: An Assessment of Preclinical Model Systems for the Study of Lung CancersAdi F Gazdar, Fred R Hirsch, John D Minna
The Lancet. Oncology|July 10, 2015
EGFR tyrosine kinase inhibitors in squamous cell lung cancerFred R Hirsch, Roy S Herbst, David R Gandara
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2014
"Companion diagnostics": has their time come and gone?Fred R Hirsch, Paul A Bunn, Roy S Herbst
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2014
Is there clinical value to prognostic signatures in early-stage NSCLC?Paul A Bunn, Fred R Hirsch, Dara L Aisner
Translational Lung Cancer Research|December 9, 2017
Potential future consideration for imaging and blood-based biomarkers for precision medicine in lung cancerFeng-Ming Spring Kong, Fred R Hirsch, Mitchell Machtay
Seminars in Oncology|July 3, 2002
Expression of target molecules in lung cancer: challenge for a new treatment paradigmFred R Hirsch, Wilbur A Franklin, Paul A Bunn
Small (Weinheim an Der Bergstrasse, Germany)|August 26, 2009
Sniffing the unique "odor print" of non-small-cell lung cancer with gold nanoparticlesOrna Barash, Nir Peled, Fred R Hirsch, et al.
Pageof 41